Skip to main contentSkip to breadcrumbsSkip to sub navSkip to doormat

News

12th Microsymposium on Small RNAs at the Vienna BioCenter


26 May 2017

The “12th Microsymposium on Small RNAs” has started at the Vienna BioCenter (VBC) today.

Featuring some of the leading scientists in the field from around the world, the symposium is running from May 26th to 28th 2017 at the VBC, sponsored by three research institutes - IMBA, IMP and GMI. 

The symposium has a strong tradition and brings together scientists in the broad field of small RNA biology, but also related RNA fields. It has an emphasis on junior PIs, postdocs, and PhD students.  

Over the years, the “Microsymposium on Small RNAs” has developed into one of the most prestigious meetings in this field, and especially the open and dynamic atmosphere of the meeting make it a great event.  

This annual occasion also strengthens the global recognition of RNA biology research done at the Vienna BioCenter; this subject links several research groups from all four VBC-based research institutes and has developed into one of the core strengths of the VBC. The symposium is in fact co-organised by group leaders from all four institutions: Stefan Ameres and Julius Brennecke (both IMBA), Luisa Cochella (IMP), Javier Martinez (MFPL) and Michael Nodine (GMI). 

More information: http://www.imba.oeaw.ac.at/news-events/events/microsymposium/ 

Speakers

Peter Brodersen
University of Copenhagen, Denmark

Marc Bühler
FMI, Switzerland

Severine Chambeyron
CNRS, Montpellier, France

Luisa Cochella
Institute of Molecular Pathology (IMP), Austria

Dan Dominissini
Sheba Medical Center affiliated with Tel-Aviv University

Hailing Jin
University of California, Riverside, USA

Nelson Lau
Brandeis University, United States

Judy Lieberman
Harvard Medical School, United States

Rob Martienssen
Cold Spring Harbor Laboratory, United States

Jean-Yves Roignant
IMB Mainz, Germany

Mikiko Siomi
Keio University School of Medicine, Japan

Keith Slotkin
The Ohio State University, United States

Nick Sokol
Indiana University, Bloomington, United States

Katalin Fejes Tóth
Caltech, United States

Igor Ulitsky
Weizmann Institute of Science, Israel

Juanma Vaquerizas
Max Planck Institute, Germany

Blake Wiedenheft
Montana State University, United States

Mihaela Zavolan
University of Basel, Switzerland

Daniel Zilberman
UC Berkeley, United States


About the Vienna BioCenter

The Vienna BioCenter (VBC) is a leading life sciences location in Europe, offering an extraordinary combination of research, education and business on a single campus. About 1,600 employees, more than 1,000 students, 93 research groups, 16 biotech companies, and scientists from more than 40 nations create a highly dynamic environment. See: http://www.viennabiocenter.org 

About the IMP

The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 37 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, neurobiology, disease mechanisms and computational biology.